William Plovanic
Stock Analyst at Canaccord Genuity
(3.29)
# 1,119
Out of 4,413 analysts
82
Total ratings
42.53%
Success rate
3.37%
Average return
Main Sectors:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $32 → $14 | $9.78 | +43.15% | 3 | May 1, 2024 | |
| DXCM DexCom | Maintains: Buy | $144 → $145 | $128.19 | +13.12% | 1 | Apr 26, 2024 | |
| NARI Inari Medical | Maintains: Buy | $75 | $42.71 | +75.60% | 8 | Apr 12, 2024 | |
| SWAV ShockWave Medical | Downgrades: Hold | $263 → $335 | $330.57 | +1.34% | 6 | Apr 5, 2024 | |
| PEN Penumbra | Reiterates: Buy | $284 | $208.36 | +36.30% | 4 | Feb 23, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $121 → $133 | $112.63 | +18.09% | 6 | Feb 23, 2024 | |
| NVRO Nevro | Downgrades: Hold | $23 | $10.99 | +109.28% | 8 | Dec 21, 2023 | |
| BVS Bioventus | Upgrades: Buy | $3.66 → $7 | $4.03 | +73.91% | 1 | Dec 7, 2023 | |
| BSX Boston Scientific | Maintains: Buy | $60 → $64 | $72.86 | -12.16% | 5 | Nov 27, 2023 | |
| LUNG Pulmonx | Maintains: Buy | $20 → $12 | $7.90 | +51.90% | 4 | Oct 31, 2023 | |
| ANGO AngioDynamics | Maintains: Buy | $20 → $17 | $5.90 | +188.38% | 3 | Oct 5, 2023 | |
| MMSI Merit Medical Systems | Maintains: Hold | $86 → $70 | $77.13 | -9.24% | 4 | Aug 28, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Hold | $77 → $48 | $45.67 | +5.11% | 5 | Aug 3, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $21 → $22 | $16.63 | +32.29% | 3 | Jul 25, 2023 | |
| TMDX TransMedics Group | Maintains: Buy | $91 → $86 | $121.71 | -29.34% | 3 | May 18, 2023 | |
| STIM Neuronetics | Maintains: Buy | $9 → $7 | $3.62 | +93.64% | 1 | Mar 8, 2023 | |
| ATRC AtriCure | Maintains: Buy | $81 → $74 | $24.81 | +198.33% | 6 | Feb 22, 2023 | |
| EW Edwards Lifesciences | Maintains: Hold | $68 → $76 | $85.55 | -11.16% | 5 | Feb 1, 2023 | |
| VAPO Vapotherm | Downgrades: Hold | $96 → $40 | $1.19 | +3,250.08% | 2 | May 6, 2022 | |
| AFIB Acutus Medical | Downgrades: Hold | $10 → $3 | $0.15 | +1,869.80% | 4 | Jan 14, 2022 |
CVRx, Inc.
May 1, 2024
Maintains: Buy
Price Target: $32 → $14
Current: $9.78
Upside: +43.15%
DexCom
Apr 26, 2024
Maintains: Buy
Price Target: $144 → $145
Current: $128.19
Upside: +13.12%
Inari Medical
Apr 12, 2024
Maintains: Buy
Price Target: $75
Current: $42.71
Upside: +75.60%
ShockWave Medical
Apr 5, 2024
Downgrades: Hold
Price Target: $263 → $335
Current: $330.57
Upside: +1.34%
Penumbra
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $208.36
Upside: +36.30%
iRhythm Technologies
Feb 23, 2024
Maintains: Buy
Price Target: $121 → $133
Current: $112.63
Upside: +18.09%
Nevro
Dec 21, 2023
Downgrades: Hold
Price Target: $23
Current: $10.99
Upside: +109.28%
Bioventus
Dec 7, 2023
Upgrades: Buy
Price Target: $3.66 → $7
Current: $4.03
Upside: +73.91%
Boston Scientific
Nov 27, 2023
Maintains: Buy
Price Target: $60 → $64
Current: $72.86
Upside: -12.16%
Pulmonx
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $7.90
Upside: +51.90%
AngioDynamics
Oct 5, 2023
Maintains: Buy
Price Target: $20 → $17
Current: $5.90
Upside: +188.38%
Merit Medical Systems
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $77.13
Upside: -9.24%
STAAR Surgical Company
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $45.67
Upside: +5.11%
Y-mAbs Therapeutics
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $16.63
Upside: +32.29%
TransMedics Group
May 18, 2023
Maintains: Buy
Price Target: $91 → $86
Current: $121.71
Upside: -29.34%
Neuronetics
Mar 8, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $3.62
Upside: +93.64%
AtriCure
Feb 22, 2023
Maintains: Buy
Price Target: $81 → $74
Current: $24.81
Upside: +198.33%
Edwards Lifesciences
Feb 1, 2023
Maintains: Hold
Price Target: $68 → $76
Current: $85.55
Upside: -11.16%
Vapotherm
May 6, 2022
Downgrades: Hold
Price Target: $96 → $40
Current: $1.19
Upside: +3,250.08%
Acutus Medical
Jan 14, 2022
Downgrades: Hold
Price Target: $10 → $3
Current: $0.15
Upside: +1,869.80%